Insights

Growth momentum OPKO Health shows ongoing revenue growth with quarterly revenues around $163-164 million and a total funding runway of $686M, indicating a scalable opportunity for advanced diagnostics services, clinical products distribution, and contract manufacturing partnerships.

Diagnostics expansion The company owns BioReference Laboratories and GeneDx, highlighting strong diagnostics capabilities and potential cross-sell of assay development, genomic testing, and integrated lab services to researchers and healthcare systems.

R&D pipeline A robust and diverse R&D portfolio including OPK8801001 and multispecific antibodies via ModeX Therapeutics suggests opportunities for collaboration on research solutions, clinical trial support, biomarker analytics, and partnering in early-stage development.

Strategic collaborations Recent partnerships in multispecific antibodies with Regeneron and ongoing ENDO conference presence indicate a readiness to engage in strategic alliances, licensing discussions, and joint ventures for novel therapeutic modalities.

Global and digital Operating across nine countries with a modern tech stack (AWS, SAP, Salesforce, iCIMS) implies opportunities to optimize supply chain, ERP, CRM-driven upsell for enterprise customers, and digital transformation services to scale operations.

Similar companies to OPKO Health, Inc.

OPKO Health, Inc. Tech Stack

OPKO Health, Inc. uses 8 technology products and services including iCIMS, Amazon Web Services, Drupal, and more. Explore OPKO Health, Inc.'s tech stack below.

Media & News

OPKO Health, Inc.'s Email Address Formats

OPKO Health, Inc. uses at least 4 email formats:
OPKO Health, Inc. Email FormatsExamplePercentage
FLast@opko.comJDoe@opko.com
90%
LFirst@opko.comDJohn@opko.com
7%
FirstLast@opko.comJohnDoe@opko.com
2%
First.Last@opko.comJohn.Doe@opko.com
1%

Frequently Asked Questions

What is OPKO Health, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact OPKO Health, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OPKO Health, Inc.'s stock symbol?

Minus sign iconPlus sign icon
OPKO Health, Inc. is a publicly traded company; the company's stock symbol is OPK.

What is OPKO Health, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
OPKO Health, Inc.'s official website is opko.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does OPKO Health, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, OPKO Health, Inc.'s annual revenue is estimated to be $500M - $1B.

What is OPKO Health, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
OPKO Health, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OPKO Health, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, OPKO Health, Inc. has approximately 2K employees across 5 continents, including North America, South America and Europe. Key team members include CFO Latam & Mexico Operations Lead: D. V. H., Chief Product Officer: A. K. and Chief Financial Officer: A. E. K. Explore OPKO Health, Inc.'s employee directory with LeadIQ.

What industry does OPKO Health, Inc. belong to?

Minus sign iconPlus sign icon
OPKO Health, Inc. operates in the Biotechnology Research industry.

What technology does OPKO Health, Inc. use?

Minus sign iconPlus sign icon
OPKO Health, Inc.'s tech stack includes iCIMS, Amazon Web Services, Drupal, WordPress, Salesforce, SAP, Imperva and SAP Concur.

What is OPKO Health, Inc.'s email format?

Minus sign iconPlus sign icon
OPKO Health, Inc.'s email format typically follows the pattern of FLast@opko.com. Find more OPKO Health, Inc. email formats with LeadIQ.

How much funding has OPKO Health, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, OPKO Health, Inc. has raised $686M in funding. The last funding round occurred on Aug 17, 2024 for $250M.

When was OPKO Health, Inc. founded?

Minus sign iconPlus sign icon
OPKO Health, Inc. was founded in 2007.
OPKO Health, Inc. logo

OPKO Health, Inc.

Biotechnology ResearchFlorida, United States1001-5000 Employees

OPKO Health, Inc. is a biotechnology company based in Miami, Florida, pursuing unmet patient needs through a combination of first-in-class products, a diagnostics division, and an active research and development pipeline. Its portfolio includes Rayaldee (calcifediol) and the 4Kscore test, supported by BioReference Laboratories and GeneDx within its diagnostics operations. Founded in 2007 by Dr. Phillip Frost, the company has grown to a global presence spanning nine countries.

Operating in the biotechnology research industry, OPKO integrates clinical products, diagnostics, and biomedical development to address evolving patient needs. In 2026, the company reported progress through its ModeX Therapeutics unit with the development of a tetraspecific antibody for B-cell lymphomas, signaling ongoing expansion of its therapeutic research.

Section iconCompany Overview

Phone number
Website
opko.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
OPK
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
1001-5000

Section iconFunding & Financials

  • $686M

    OPKO Health, Inc. has raised a total of $686M of funding over 4 rounds. Their latest funding round was raised on Aug 17, 2024 in the amount of $250M as a Post IPO Debt.

  • $500M - $1B

    OPKO Health, Inc.'s revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.